Simulations Plus, Inc. is a provider of modeling and simulation software and services for pharmaceutical drug discovery and development, including the prediction of properties of molecules utilizing both artificial intelligence and machine-based technology. Its segments include software and services. It offers 12 software products for pharmaceutical research and development: GastroPlus, DDDPlus, MembranePlus, DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, MonolixSuite, ADMET Predictor and MedChem Designer. Its services include population pharmacokinetic and pharmacodynamic, quantitative systems pharmacology/quantitative systems toxicology, and physiologically based pharmacokinetic. We show 67 historical shares outstanding datapoints in our SLP shares outstanding history coverage, used to compute SLP market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing SLP market cap history over the course of time is important for investors
interested in comparing SLP's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of SLP versus a peer is one thing; comparing
SLP market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like SLP can fluctuate over the course of history.
With this page we aim to empower investors researching SLP by allowing them to research the SLP market cap history. |
Free SLP Email Alerts:
Video: The Importance of Market Cap
